Revvity | PKI - Operating Expenses



Revvity reported $629.52M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Adcock Ingram Holdings ZAR 4.23B 196.72M Dec/2024
Agilent USD 1.38B 10M Jul/2025
Align Technology USD 849.42M 1.25M Jun/2025
Bio Techne USD 340.82M 63.35M Jun/2025
Bio-Rad Laboratories USD 574.5M 12.8M Jun/2025
Bruker USD 785.5M 15.9M Jun/2025
Celltrion KRW 718.99B 24.68B Jun/2025
Charles River Laboratories USD 899.8M 9.7M Jun/2025
Cspc Pharmaceutical CNY 5.22B 248.9M Mar/2025
Danaher USD 5.18B 718M Jun/2025
Dentsply International USD 825M 9M Jun/2025
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Divis Laboratories Ltd 17.93B 130M Jun/2025
Edwards Lifesciences USD 1.1B 83.4M Jun/2025
Exact Sciences USD 813.23M 10.44M Jun/2025
Hologic USD 762.9M 249.4M Jun/2025
Illumina USD 845M 65M Jun/2025
Intuitive Surgical USD 1.69B 17.8M Jun/2025
IQVIA Holdings USD 3.46B 124M Jun/2025
Kangmei Pharma CNY 1.25B 35.75M Jun/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 132.33M 179.02M Jun/2025
Laboratory Of America USD 3.06B 51.8M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 19.8M 9.46M Dec/2024
Mettler Toledo International USD 717.51M 35.71M Jun/2025
Myriad Genetics USD 224.9M 24.7M Mar/2025
Neuren Pharmaceuticals AUD 17.41M 2.86M Dec/2024
Organigram Holdings CAD 72.9M 18.86M Jun/2025
Pharma Mar EUR 32.29M 9.66M Jun/2025
Qiagen NV USD 397.57M 39.27M Jun/2025
Quest Diagnostics USD 2.32B 17M Jun/2025
Quidel USD 615.7M 28.4M Jun/2025
Repligen USD 176.41M 13.82M Jun/2025
Revvity USD 629.52M 36.99M Jun/2025
Sartorius EUR 722.5M 23.1M Jun/2025
Sino Biopharmaceutical CNY 11.66B 352.34M Dec/2024
Thermo Fisher Scientific USD 8.94B 291M Jun/2025
Tilray USD 253.17M 16.55M Nov/2024
Waters USD 583.12M 73.16M Jun/2025
Zz Pientze Pharmaceu 1.68B 272.39M Jun/2025